The Drug Controller General of India (DCGI) has decided to grant licence to manufacturers of industrial oxygen to produce oxygen for medical use in public interest in the wake of the coronavirus outbreak.
The DGCI has asked all state and union territory drug controllers to take action for granting licence to manufacturers of industrial oxygen to make oxygen for medical use.
In a letter, the DCGI said that supplemental oxygen therapy is part of clinical management of COVID-19patients and therefore, it is imperative to ensure the availability and supply of oxygen medical use across the country.
He said that the All India Industrial Gases Manufactures' Association has proposed for allowing manufactures of industrial oxygen to produce for medical use.
"...to ensure the availability and supply of oxygen for medical use it has been decided in public interest that premises which are having facility to manufacture industrial oxygen should be granted manufacturing licence to manufacture oxygen for medical use within 24 hours of receiving the application, fees, etc. as per the Drugs and Cosmetics Act, 1940 and rules," the DGCI said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
